BDSX Q3 2020 Earnings — Biodesix, Inc. Revenue & Financial Results | Market Cap Arena

BDSXBiodesix, Inc.

$138M

Q3 2020 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$9M+133.2% YoY

Gross Profit

$5M57.7% margin

Operating Income

-$6M-67.9% margin

Net Income

-$9M-96.2% margin

EPS (Diluted)

$-0.33

QoQ Revenue Growth

+116.9%

Cash Flow

Operating Cash Flow

$0

Free Cash Flow

$0

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$47M

Total Liabilities

$302M

Stockholders' Equity

-$255M

Cash & Equivalents

$6M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$9M	$4M	+133.2%
Gross Profit	$5M	$2M	+117.4%
Operating Income	-$6M	-$9M	+30.9%
Net Income	-$9M	-$10M	+7.9%

Revenue Segments

Diagnostic Tests

$9M100%